Patent · US Active

Isolated genomic polynucleotide fragments encoding human resistin and the human syntaxin binding protein 2

US7470522B1 · kind B1 · utility

3Cited by
0References
16Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJul 7, 2006
Grant dateDec 30, 2008
Priority date
Expiry dateJul 7, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/4716
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention is directed to isolated genomic polynucleotide fragments that encode human resistin and human syntaxin binding protein 2, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human resistin and human syntaxin binding protein 2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.